Ryan Cohlhepp is President & COO at Bicara Therapeutics Inc. (BCAX). They have made 1 open-market trade across 1 company since 2025, most recently 2026-09-08.
CIK 0002034665
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BCAX | 181,641 | $3.0M |
Shares reported on the most recent Form 4, priced at the 2026-09-10 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BCAX | SELL · 10b5-1 | 2026-09-08 | 2026-09-10 | $22.90 | $401K | -2.5% | -25.8% | — |
| BCAX | SELL · 10b5-1 | 2026-08-10 | 2026-08-12 | $27.98 | $525K | -3.2% | -6.2% | — |
| BCAX | SELL · 10b5-1 | 2026-07-08 | 2026-07-10 | $28.98 | $833K | -0.2% | -1.3% | -38.6% |
| BCAX | SELL · 10b5-1 | 2026-05-15 | 2026-05-18 | $20.29 | $254K | +14.2% | +20.5% | +31.0% |
| BCAX | SELL · 10b5-1 | 2026-04-15 | 2026-04-17 | $23.01 | $288K | -10.4% | -18.8% | +16.0% |
| BCAX | SELL · 10b5-1 | 2026-03-16 | 2026-03-17 | $19.66 | $491K | -4.3% | +24.7% | +12.3% |
| BCAX | SELL | 2026-03-03 | 2026-03-05 | $18.16 | $316K | +5.9% | +14.2% | +9.5% |
| BCAX | SELL · 10b5-1 | 2026-02-25 | 2026-02-27 | $18.04 | $66K | +22.8% | +17.5% | +34.3% |
| BCAX | SELL · 10b5-1 | 2026-01-22 | 2026-01-26 | $18.10 | $69K | -8.3% | +6.3% | +36.5% |
| BCAX | SELL · 10b5-1 | 2026-01-15 | 2026-01-20 | $18.02 | $3K | +1.2% | -7.1% | +41.4% |
| BCAX | SELL · 10b5-1 | 2025-12-15 | 2025-12-16 | $18.68 | $234K | -8.8% | -7.8% | +7.2% |
| BCAX | SELL · 10b5-1 | 2025-11-21 | 2025-11-25 | $18.05 | $226K | +2.7% | -8.7% | -10.9% |
| BCAX | SELL · 10b5-1 | 2025-10-15 | 2025-10-16 | $18.16 | $227K | -6.8% | -17.9% | -1.7% |
| BCAX | SELL · 10b5-1 | 2025-10-06 | 2025-10-08 | $18.06 | $1.4M | -9.1% | -18.2% | -9.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.